BLOG
LighthouseAI: AI-Powered Compliance
LAUNCH OF LIGHTHOUSEAI™, AN AI-BASED VENTURE UNIT TO SOLVE COMMERCIAL REGULATORY COMPLIANCE FOR THE LIFE SCIENCES INDUSTRY | by: Sumeet Singh, Founder & Chairman | Article Posted: February 1, 2023 | Pharma Solutions, a leading provider of compliance services in...
Recent Articles
Top 5 Most Common PSL Findings
Top 5 Most Common PSL Findings Overview: NABP DDA accreditation consists of three main parts, which are the application review, policy &...
Drug Pricing Transparency Fight Rages On
Even as the COVID-19 pandemic disrupts day-to-day life, drug pricing transparency rages on between consumer groups, regulators, and industry. Regulators are now having to resort to assessing significant fines to increase compliance.
Shipping Office Stock vs. Prescriptions: $15M Case Study for Omnicare
Omnicare, a leading provider of closed-door pharmacy services, agreed to pay more than a $15 million civil penalty for allowing opioids and other controlled substances to be dispensed without a valid prescription. The fine zeroes in on a common issue amongst pharmacies – discerning between office stock and shipping pursuant to a prescription.
Pharma Solutions Submits Comments on New PR Rule
Pharma Solutions Submits Comments on New PR Rule Pharma Solutions is making public comments on the Puerto Rico Department of Health’s proposed...
Puerto Rico DOH Portal Update
Pharma Solutions continues to stay on top of developments with the Puerto Rico Department of Health’s portal. In early April 2020, issues with their technology provider brought the entire web portal down, preventing submission for both drug registrations and controlled substance licensing.
COVID-19 Shortages: Boom or Bust for Business?
This week, we explore how to legally and ethically navigate supplying products during the pandemic. It is the wild west in the hospital supply business – from illegal import practices and price-gouging to ingenious manufacturing and extra hours.
